Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
June 02 2015 - 04:25PM
Edgar (US Regulatory)
|
|
|
|
|
May 2015
Pricing Sheet dated May 29,
2015 relating to Preliminary Terms No. 367 dated April 29, 2015
Registration Statement No. 333-199966 Filed pursuant to Rule 433 |
STRUCTURED INVESTMENTS
Opportunities in U.S. Equities
PLUS Based on the Value of the S&P 500® Index due September 6, 2016
Performance Leveraged Upside SecuritiesSM
Principal at Risk Securities
|
|
|
PRICING TERMS
May 29, 2015 |
|
|
Issuer: |
|
JPMorgan Chase & Co. |
Underlying index: |
|
S&P 500® Index |
Aggregate principal amount: |
|
$9,146,940 |
Payment at maturity: |
|
If the final index value is greater than the initial index value, for each $10 stated principal amount PLUS,
$10 + leveraged upside payment
In no event will the payment at maturity exceed the maximum payment at maturity.
If the final index value is less than or equal to the initial index value, for each $10 stated principal amount PLUS,
$10 × index performance factor
This amount will be less than or equal to the stated principal amount of $10 per PLUS. |
Leveraged upside payment: |
|
$10 × leverage factor × index percent increase |
Index percent increase: |
|
(final index value initial index value) / initial index value |
Initial index value: |
|
The closing level of the underlying index on the pricing date, which was 2,107.39 |
Final index value: |
|
The closing level of the underlying index on the valuation date |
Leverage factor: |
|
300% |
Index performance factor: |
|
final index value / initial index value |
Maximum payment at maturity: |
|
$11.20 (112.00% of the stated principal amount) per PLUS. |
Stated principal amount: |
|
$10 per PLUS |
Issue price: |
|
$10 per PLUS (see Commissions and issue price below) |
Pricing date: |
|
May 29, 2015 |
Original issue date (settlement date): |
|
June 3, 2015 |
Valuation date: |
|
August 31, 2016, subject to postponement in the event of certain market disruption events and as described under General Terms of Notes Postponement of a Determination
Date in the accompanying product supplement no. 4a-I |
Maturity date: |
|
September 6, 2016, subject to postponement in the event of certain market disruption events and as described under General Terms of Notes Postponement of a
Payment Date in the accompanying product supplement no. 4a-I |
CUSIP / ISIN: |
|
48127T186 / US48127T1869 |
Listing: |
|
The PLUS will not be listed on any securities exchange. |
Agent: |
|
J.P. Morgan Securities LLC (JPMS) |
|
|
|
|
|
|
|
|
|
Commissions and issue price: |
|
Price to public(1) |
|
Fees and commissions |
|
Proceeds to issuer |
Per PLUS |
|
$10 |
|
$0.175(2) |
|
$9.775 |
|
|
|
|
$0.05(3) |
|
|
Total |
|
$9,146,940.00 |
|
$205,806.15 |
|
$8,941,133.85 |
|
(1) |
See Additional Information about the PLUS Supplemental use of proceeds and hedging in the accompanying preliminary terms for information about the
components of the price to public of the PLUS. |
|
(2) |
JPMS, acting as agent for JPMorgan Chase & Co., will pay all of the selling commissions of $0.175 per $10 stated principal amount PLUS it receives from us to Morgan
Stanley Smith Barney LLC (Morgan Stanley Wealth Management). See Plan of Distribution (Conflicts of Interest) beginning on page PS-87 of the accompanying product supplement no. 4a-I. |
|
(3) |
Reflects a structuring fee payable to Morgan Stanley Wealth Management by the agent or its affiliates of $0.05 for each PLUS |
The estimated value of the PLUS on the pricing date as determined by JPMS was $9.735 per $10 stated principal amount PLUS. See Additional
Information about the PLUS JPMSs estimated value of the PLUS in the accompanying preliminary terms for additional information.
The PLUS are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or
guaranteed by, a bank.
You should read this document together with the preliminary terms describing the offering and the related
product supplement no. 4a-I, underlying supplement no. 1a-I, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see Additional Information about the PLUS in the accompanying
preliminary terms.
Preliminary terms no. 367 dated April
29, 2015: http://www.sec.gov/Archives/edgar/data/19617/000089109215003657/e63941fwp.htm
Product supplement no. 4a-I dated November
7, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214008407/e61359_424b2.pdf
Underlying supplement no. 1a-I dated November
7, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214008410/e61337_424b2.pdf
Prospectus supplement and prospectus, each dated November
7, 2014: http://www.sec.gov/Archives/edgar/data/19617/000089109214008397/e61348_424b2.pdf
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the SEC) for the offering to which this communication relates. Before you invest, you
should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web
site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling toll-free (800) 869-3326.
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Feb 2024 to Mar 2024
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Mar 2023 to Mar 2024